We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Janus mutual fund, which was established in 2017 following the merger of Janus Capital Group and Henderson Global Investors, oversees $334.9 billion worth of client assets under management (AUM). The company has a team of over 340 investment professionals spread across 24 offices worldwide. Their client-oriented approach, expertise, global reach and commitment to transparency make them attractive options for investment.
From an investment standpoint, we have selected three Janus mutual funds that are anticipated to safeguard one's portfolio and offer appealing returns. Mutual funds, in general, reduce transaction costs and diversify the portfolio without commission charges mostly associated with stock purchases (read more: Mutual Funds: Advantages, Disadvantages, and How They Make Investors Money).
These mutual funds, by the way, boast a Zacks Mutual Fund Rank #1 (Strong Buy) or 2 (Buy), have positive three-year and five-year annualized returns, minimum initial investments within $5,000 and carry a low expense ratio.
Janus Henderson Enterprise Fund (JANEX - Free Report) invests in common stocks of medium-sized companies whose market cap aligns with those on the Russell Midcap Growth Index.
Brian Demain has been the lead manager of JANEX since Oct 31, 2007. Most of the fund's holdings were in companies like Constellation Software Inc (3.6%), ON Semiconductor Corp (3.2%) and Boston Scientific Corp (3%) as of Sep 30, 2023.
JANEX's 3-year and 5-year returns are 5.1% and 13.6%, respectively. The annual expense ratio is 0.79% compared with the category average of 1.09%. JANEX has a Zacks Mutual Fund Rank #1.
To see how this fund performed compared to its category and other 1 and 2 Ranked Mutual Funds, please click here.
Janus Henderson Global Life Sciences Fund (JNGLX - Free Report) invests its net assets in securities issued by firms that have a life science emphasis to meet its investment goal. JNGLX has created a fundamental policy mandating a minimum investment of its total assets in securities issued by firms categorized under the "life sciences" sector as part of its strategy to locate such companies.
Andy Acker has been the lead manager of JNGLX since Apr 30, 2007. Most of the fund's holdings were in companies like UnitedHealth Group Inc (6.8%), Eli Lilly and Co (4.8%) and AstraZeneca PLC (4.1%) as of Sep 30, 2023.
JNGLX's 3-year and 5-year returns are 3.8% and 12.6%, respectively. The annual expense ratio is 0.80% compared with the category average of 1.03%. JNGLX has a Zacks Mutual Fund Rank #2.
Janus Henderson Mid Cap Value Fund (JNMCX - Free Report) invests in equity securities of mid-sized companies whose market capitalization falls in the range of the Russell Midcap Value Index.
Justin Tugman has been the lead manager of JNMCX since Mar 18, 2015. Most of the fund's holdings were in companies like The Hartford Financial Services Group, Inc. (2.6%), Cardinal Health, Inc. (2.5%) and Chesapeake Energy Corporation (2.5%) as of Sep 30, 2023.
JNMCX's 3-year and 5-year returns are 8.1% and 10.2%, respectively. The annual expense ratio is 0.63% compared with the category average of 1.01%. JNMCX has a Zacks Mutual Fund Rank #2.
Want key mutual fund info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
3 Janus Mutual Funds for Scintillating Returns
Janus mutual fund, which was established in 2017 following the merger of Janus Capital Group and Henderson Global Investors, oversees $334.9 billion worth of client assets under management (AUM). The company has a team of over 340 investment professionals spread across 24 offices worldwide. Their client-oriented approach, expertise, global reach and commitment to transparency make them attractive options for investment.
From an investment standpoint, we have selected three Janus mutual funds that are anticipated to safeguard one's portfolio and offer appealing returns. Mutual funds, in general, reduce transaction costs and diversify the portfolio without commission charges mostly associated with stock purchases (read more: Mutual Funds: Advantages, Disadvantages, and How They Make Investors Money).
These mutual funds, by the way, boast a Zacks Mutual Fund Rank #1 (Strong Buy) or 2 (Buy), have positive three-year and five-year annualized returns, minimum initial investments within $5,000 and carry a low expense ratio.
Janus Henderson Enterprise Fund (JANEX - Free Report) invests in common stocks of medium-sized companies whose market cap aligns with those on the Russell Midcap Growth Index.
Brian Demain has been the lead manager of JANEX since Oct 31, 2007. Most of the fund's holdings were in companies like Constellation Software Inc (3.6%), ON Semiconductor Corp (3.2%) and Boston Scientific Corp (3%) as of Sep 30, 2023.
JANEX's 3-year and 5-year returns are 5.1% and 13.6%, respectively. The annual expense ratio is 0.79% compared with the category average of 1.09%. JANEX has a Zacks Mutual Fund Rank #1.
To see how this fund performed compared to its category and other 1 and 2 Ranked Mutual Funds, please click here.
Janus Henderson Global Life Sciences Fund (JNGLX - Free Report) invests its net assets in securities issued by firms that have a life science emphasis to meet its investment goal. JNGLX has created a fundamental policy mandating a minimum investment of its total assets in securities issued by firms categorized under the "life sciences" sector as part of its strategy to locate such companies.
Andy Acker has been the lead manager of JNGLX since Apr 30, 2007. Most of the fund's holdings were in companies like UnitedHealth Group Inc (6.8%), Eli Lilly and Co (4.8%) and AstraZeneca PLC (4.1%) as of Sep 30, 2023.
JNGLX's 3-year and 5-year returns are 3.8% and 12.6%, respectively. The annual expense ratio is 0.80% compared with the category average of 1.03%. JNGLX has a Zacks Mutual Fund Rank #2.
Janus Henderson Mid Cap Value Fund (JNMCX - Free Report) invests in equity securities of mid-sized companies whose market capitalization falls in the range of the Russell Midcap Value Index.
Justin Tugman has been the lead manager of JNMCX since Mar 18, 2015. Most of the fund's holdings were in companies like The Hartford Financial Services Group, Inc. (2.6%), Cardinal Health, Inc. (2.5%) and Chesapeake Energy Corporation (2.5%) as of Sep 30, 2023.
JNMCX's 3-year and 5-year returns are 8.1% and 10.2%, respectively. The annual expense ratio is 0.63% compared with the category average of 1.01%. JNMCX has a Zacks Mutual Fund Rank #2.
Want key mutual fund info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>